Anti-5HT2A/ HTR2A/ 5-HT2A monoclonal antibody

Anti-5HT2A/ HTR2A/ 5-HT2A antibody for FACS & in-vivo assay

Target products collectionGo to HTR2A/HTR2A products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-T32060-Ab-1/ GM-Tg-hg-T32060-Ab-2Anti-Human HTR2A monoclonal antibodyHuman
GM-Tg-rg-T32060-Ab-1/ GM-Tg-rg-T32060-Ab-2Anti-Rat HTR2A monoclonal antibodyRat
GM-Tg-mg-T32060-Ab-1/ GM-Tg-mg-T32060-Ab-2Anti-Mouse HTR2A monoclonal antibodyMouse
GM-Tg-cynog-T32060-Ab-1/ GM-Tg-cynog-T32060-Ab-2Anti-Cynomolgus/ Rhesus macaque HTR2A monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-T32060-Ab-1/ GM-Tg-felg-T32060-Ab-2Anti-Feline HTR2A monoclonal antibodyFeline
GM-Tg-cang-T32060-Ab-1/ GM-Tg-cang-T32060-Ab-2Anti-Canine HTR2A monoclonal antibodyCanine
GM-Tg-bovg-T32060-Ab-1/ GM-Tg-bovg-T32060-Ab-2Anti-Bovine HTR2A monoclonal antibodyBovine
GM-Tg-equg-T32060-Ab-1/ GM-Tg-equg-T32060-Ab-2Anti-Equine HTR2A monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-T32060-Ab-1/ GM-Tg-hg-T32060-Ab-2; GM-Tg-rg-T32060-Ab-1/ GM-Tg-rg-T32060-Ab-2;
GM-Tg-mg-T32060-Ab-1/ GM-Tg-mg-T32060-Ab-2; GM-Tg-cynog-T32060-Ab-1/ GM-Tg-cynog-T32060-Ab-2;
GM-Tg-felg-T32060-Ab-1/ GM-Tg-felg-T32060-Ab-2; GM-Tg-cang-T32060-Ab-1/ GM-Tg-cang-T32060-Ab-2;
GM-Tg-bovg-T32060-Ab-1/ GM-Tg-bovg-T32060-Ab-2; GM-Tg-equg-T32060-Ab-1/ GM-Tg-equg-T32060-Ab-2
Products NameAnti-HTR2A monoclonal antibody
Formatmab
Target NameHTR2A
Protein Sub-locationTransmembrane Protein
Category of antibodyFACS/Biofunctional Antibody, Therapeutics Target antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by using flow cytometry with antigen overexpressed cell line. The biofunction of antibodies are validated in cell-based assay (IC50 or EC50 TBD).
TagFc
Products descriptionPre-made anti-HTR2A benchmark inhibitory monoclonal antibody(mab) (blocking antibody inhibitor) is expressed by mammalian cell line as a benchmark antibody for cell culture, FACS,ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation Lyophilized from sterile PBS, PH 7.4
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenProducts DevelopingMulti-species 5HT2A/ HTR2A/ 5-HT2A VLP (virus-like particle) (Products Developing)
    ORF Viral VectorvGMAP000503human HTR2A Adenovirus particle
    ORF Viral VectorpGMAP000503human HTR2A Adenovirus plasmid
    ORF Viral VectorpGMLP002120human HTR2A Lentivirus plasmid
    ORF Viral VectorvGMLP002120human HTR2A Lentivirus particle
    ORF Viral VectorpGMLPm002960mouse Htr2a Lentivirus plasmid
    ORF Viral VectorvGMLPm002960mouse Htr2a Lentivirus particle


    Target information

    Target IDGM-T32060
    Target NameHTR2A
    Gene ID3356,15558,29595,613032,403882,101081108,407230,100009685
    Gene Symbol and Synonyms5-HT-2,5-HT-2A,5-HT2A,5-HTR2A,5Ht-2,5HT2A,5HTR2A,E030013E04,Htr-2,HTR2,HTR2A
    Uniprot AccessionP28223,P14842,P50128,O46635,Q75Z89
    Uniprot Entry Name5HT2A_HUMAN,5HT2A_MACMU,5HT2A_RAT,5HT2A_CANLF,5HT2A_BOVIN
    Protein Sub-locationTransmembrane Protein
    CategoryTherapeutics Target
    DiseaseSchizophrenia
    Gene EnsemblENSG00000102468
    Target ClassificationGPCR

    The target: HTR2A, gene name: HTR2A, also named as 5-HT2A, HTR2. This gene encodes one of the receptors for serotonin, a neurotransmitter with many roles. Mutations in this gene are associated with susceptibility to schizophrenia and obsessive-compulsive disorder, and are also associated with response to the antidepressant citalopram in patients with major depressive disorder (MDD). MDD patients who also have a mutation in intron 2 of this gene show a significantly reduced response to citalopram as this antidepressant downregulates expression of this gene. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Sep 2009].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.